ArticleCancer immunology, immunotherapy : CII2022

Selection of antibody and light exposure regimens alters therapeutic effects of EGFR-targeted near-infrared photoimmunotherapy.

Ryuhei Okada et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.